JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 31 filers reported holding JANUX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,389,772 | -10.2% | 9,165,652 | +5.7% | 1.82% | -6.4% |
| Q2 2023 | $102,920,544 | -1.9% | 8,670,644 | 0.0% | 1.94% | -18.2% |
| Q1 2023 | $104,914,792 | -8.1% | 8,670,644 | 0.0% | 2.38% | +2.5% |
| Q4 2022 | $114,192,381 | -2.7% | 8,670,644 | 0.0% | 2.32% | -7.5% |
| Q3 2022 | $117,401,000 | +10.9% | 8,670,644 | 0.0% | 2.50% | -11.3% |
| Q2 2022 | $105,869,000 | -14.9% | 8,670,644 | 0.0% | 2.82% | +4.1% |
| Q1 2022 | $124,337,000 | -27.3% | 8,670,644 | 0.0% | 2.71% | -10.0% |
| Q4 2021 | $171,072,000 | -8.8% | 8,670,644 | 0.0% | 3.02% | +16.0% |
| Q3 2021 | $187,546,000 | -13.3% | 8,670,644 | 0.0% | 2.60% | -25.1% |
| Q2 2021 | $216,333,000 | – | 8,670,644 | – | 3.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |